A recently developed typhoid vi polysaccharide vaccine: Rationale and clinical profile

BioDrugs

Volumn 15, Issue SUPPL. 1, 2001, Pages 1-4

  Zuckerman, Jane N ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Academic Centre for Travel Medicine and Vaccines   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; MEFLOQUINE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; TYPHERIX; TYPHOID VACCINE;

BACTERIAL VIRULENCE; CLINICAL TRIAL; DIARRHEA; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG TOLERABILITY; EDITORIAL; FEVER; FOOD CONTAMINATION; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; PREVALENCE; PRIORITY JOURNAL; SALMONELLA TYPHI; TYPHOID FEVER; VOMITING; WATER CONTAMINATION;

EID: 0035208281     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200115001-00001     Document Type: Editorial

References (6)

1. World Health Organization. The Children's Vaccine Initiative (CVI) and WHO'S Global Programme for Vaccines and Immunization (GPV). Recommendations from the Scientific Advisory Group of Experts (SAGE). Pt 1. Wkly Epidemiol Rec 1998; 73 (37): 281-8
2. Levine MM, Black RE, Ferreccio C, et al. Interventions to control endemic typhoid fever: field studies in Santiago, Chile. In: Association PAH, editors. Control and eradication of infectious diseases. International Organization Co-publication. Series. No. 1, 1985:37-53
3. Ivanoff B, Levine MM, Lambert PH. Vaccination against typhoid fever: present status. Bull World Health Organ 1994; 72 (6): 957-71
4. Ivanoff B. Typhoid fever: global situation and WHO recommendations. Southeast Asian J Trop Med Public Health 1995; 26: 1-6
5. The World Health Report 1996 - fighting disease, fostering development. World Health Forum 1997; 18 (1): 1-8
6. Rowe B, Ward LR, Threlfall EJ. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis 1997; 24: S106-9